SCHEMBL8961418

SCHEMBL8961418

CC(N)(N)C(=O)[O-].CC(N)(N)C(=O)[O-].[Cu+2]

nearest known ligand 0.38

Predicted protein targets (top 9)

geneUniProtsupporting neighboursconfidence
CA1 P00915 2/20 0.38
CA4 P22748 2/20 0.33
FDPS P14324 1/20 0.33
MEN1 O00255 1/20 0.32
LDHA P00338 1/20 0.32
BLM P54132 1/20 0.32
KMT2A Q03164 1/20 0.32
ALDH1A1 P00352 1/20 0.32
TSHR P16473 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15820261 0.79
Potassium Ion SCHEMBL11306810 0.79
Lithium Ion SCHEMBL26631940 0.79
Pivalate SCHEMBL1950250 0.77 CA1 (0.43) CA1CA4ALDH1A1TSHR
Pivalate SCHEMBL28706057 0.77 CA1 (0.43) CA1CA4ALDH1A1TSHR
SCHEMBL5082325 0.76
Acetic Acid SCHEMBL11464477 0.76 CA1 (0.53) CA1CA4FDPSMEN1LDHA
SCHEMBL11587159 0.74 CA1 (0.40) CA1CA4ALDH1A1TSHR
SCHEMBL11048278 0.74 GGT1 (0.32)
Tert-Butylamine SCHEMBL19171185 0.73 ALDH1A1 (0.42) CA1CA4FDPSALDH1A1TSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0693081-A1 CYCLIC COMPOUNDS AND COMPOSITIONS WHICH INHIBIT BONE RESORPTION Novartis AG (CH) 1996-01-24 EP disclosed
WO-1994024153-A1 CYCLIC COMPOUNDS AND COMPOSITIONS WHICH INHIBIT BONE RESORPTION CIBA-GEIGY AG (CH) 1994-10-27 WO disclosed